Global and China Immuno-oncology Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Immuno-oncology Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Celgene Corporation

    • Galena Biopharma

    • Hoffmann-La Roche AG

    • Pfizer Inc

    • Prometheus Therapeutics & Diagnostics

    • Novartis International AG

    • EMD Serono, Inc

    • Celldex Therapeutics

    • Johnson & Johnson

    • Merck & Co

    • Sanofi SA

    • Aduro BioTech

    • AstraZeneca, Plc

    • AbbVie, Inc

    • ImmunoCellular Therapeutics

    • Gilead Sciences Inc

    • Bristol-Myers Squibb

    • Incyte

    • Eli Lilly and Company

    • Bavarian Nordic

    • Amgen, Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Immune Checkpoint Inhibitors

    • Monoclonal Antibodies

    • Cytokine-Based Immunotherapy

    • Cancer Vaccines

    • CAR-T Cell Therapy

    Application:

    • Hospitals

    • Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Immuno-oncology Drugs Industry Overview

      • 1.1.1 Immuno-oncology Drugs Market Scope and Market Segments

      • 1.1.2 Immuno-oncology Drugs Industry Characteristics

      • 1.1.3 Global and China Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Immuno-oncology Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Immuno-oncology Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Immune Checkpoint Inhibitors

      • 1.2.2 Monoclonal Antibodies

      • 1.2.3 Cytokine-Based Immunotherapy

      • 1.2.4 Cancer Vaccines

      • 1.2.5 CAR-T Cell Therapy

    • 1.3 Global Immuno-oncology Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Immuno-oncology Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Immuno-oncology Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Immuno-oncology Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Immuno-oncology Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Immuno-oncology Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Immuno-oncology Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Immuno-oncology Drugs Industry PEST Analysis

    • 2.3 Immuno-oncology Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Immuno-oncology Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Immuno-oncology Drugs Industry

    Chapter 3 Global and China Immuno-oncology Drugs Market, by Manufacturer

    • 3.1 Global and China Immuno-oncology Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Immuno-oncology Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Immuno-oncology Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Immuno-oncology Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Immuno-oncology Drugs Market Top 3 Players

    Chapter 4 Global and China Immuno-oncology Drugs Market, by Type (2017-2028)

    • 4.1 Immuno-oncology Drugs Market Trend, by Type

    • 4.2 Global Immuno-oncology Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Immuno-oncology Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Immuno-oncology Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Immuno-oncology Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Immuno-oncology Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Immuno-oncology Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Immuno-oncology Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Immuno-oncology Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Immuno-oncology Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Immuno-oncology Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Immuno-oncology Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Immuno-oncology Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Immuno-oncology Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Immuno-oncology Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Immuno-oncology Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Immuno-oncology Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Immuno-oncology Drugs Market Analysis

    • 7.1 North America Immuno-oncology Drugs Market, by Type

    • 7.2 North America Immuno-oncology Drugs Market, by Application

    • 7.3 North America Immuno-oncology Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Immuno-oncology Drugs Market Analysis

    • 8.1 Europe Immuno-oncology Drugs Market, by Type

    • 8.2 Europe Immuno-oncology Drugs Market, by Application

    • 8.3 Europe Immuno-oncology Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Immuno-oncology Drugs Market Analysis

    • 9.1 APAC Immuno-oncology Drugs Market, by Type

    • 9.2 APAC Immuno-oncology Drugs Market, by Application

    • 9.3 APAC Immuno-oncology Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Immuno-oncology Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Immuno-oncology Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Immuno-oncology Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Immuno-oncology Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Immuno-oncology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Immuno-oncology Drugs Company Profiles

      • 11.1 Celgene Corporation

        • 11.1.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Celgene Corporation Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.1.3 Celgene Corporation Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Galena Biopharma

        • 11.2.1 Galena Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Galena Biopharma Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.2.3 Galena Biopharma Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Hoffmann-La Roche AG

        • 11.3.1 Hoffmann-La Roche AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.3.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Pfizer Inc

        • 11.4.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Pfizer Inc Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.4.3 Pfizer Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Prometheus Therapeutics & Diagnostics

        • 11.5.1 Prometheus Therapeutics & Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.5.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis International AG

        • 11.6.1 Novartis International AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis International AG Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.6.3 Novartis International AG Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 EMD Serono, Inc

        • 11.7.1 EMD Serono, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 EMD Serono, Inc Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.7.3 EMD Serono, Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Celldex Therapeutics

        • 11.8.1 Celldex Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Celldex Therapeutics Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.8.3 Celldex Therapeutics Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Johnson & Johnson

        • 11.9.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Johnson & Johnson Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.9.3 Johnson & Johnson Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Merck & Co

        • 11.10.1 Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Merck & Co Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.10.3 Merck & Co Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Sanofi SA

        • 11.11.1 Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Sanofi SA Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.11.3 Sanofi SA Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Aduro BioTech

        • 11.12.1 Aduro BioTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Aduro BioTech Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.12.3 Aduro BioTech Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 AstraZeneca, Plc

        • 11.13.1 AstraZeneca, Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 AstraZeneca, Plc Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.13.3 AstraZeneca, Plc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 AbbVie, Inc

        • 11.14.1 AbbVie, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 AbbVie, Inc Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.14.3 AbbVie, Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 ImmunoCellular Therapeutics

        • 11.15.1 ImmunoCellular Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.15.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Gilead Sciences Inc

        • 11.16.1 Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Gilead Sciences Inc Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.16.3 Gilead Sciences Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Bristol-Myers Squibb

        • 11.17.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.17.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Incyte

        • 11.18.1 Incyte Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Incyte Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.18.3 Incyte Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Eli Lilly and Company

        • 11.19.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Eli Lilly and Company Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.19.3 Eli Lilly and Company Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Bavarian Nordic

        • 11.20.1 Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Bavarian Nordic Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.20.3 Bavarian Nordic Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Amgen, Inc

        • 11.21.1 Amgen, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Amgen, Inc Immuno-oncology Drugs Product Profiles, Application and Specification

        • 11.21.3 Amgen, Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Immuno-oncology Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Immuno-oncology Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Immuno-oncology Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Immuno-oncology Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Immuno-oncology Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Immune Checkpoint Inhibitors (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Monoclonal Antibodies (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Cytokine-Based Immunotherapy (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Cancer Vaccines (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of CAR-T Cell Therapy (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Pharmacies (2017-2028)

    • Figure Global Immuno-oncology Drugs Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Immuno-oncology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Immuno-oncology Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Immuno-oncology Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Immuno-oncology Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Immuno-oncology Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Immuno-oncology Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Immuno-oncology Drugs Market Share, by Manufacturer in 2022

    • Table Global Immuno-oncology Drugs Sales Volume, by Type (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Value, by Type (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Immuno-oncology Drugs Price Trend, by Type (2017-2028)

    • Table China Immuno-oncology Drugs Sales Volume, by Type (2017-2028)

    • Table China Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Immuno-oncology Drugs Sales Value, by Type (2017-2028)

    • Table China Immuno-oncology Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Immuno-oncology Drugs Price Trend, by Type (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Volume, by Application (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Value, by Application (2017-2028)

    • Table Global Immuno-oncology Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Immuno-oncology Drugs Sales Value Share, by Application (2017-2028)

    • Table China Immuno-oncology Drugs Sales Volume, by Application (2017-2028)

    • Table China Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Immuno-oncology Drugs Sales Value, by Application (2017-2028)

    • Table China Immuno-oncology Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Immuno-oncology Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Immuno-oncology Drugs Sales Volume, by Type (2017-2028)

    • Table North America Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Immuno-oncology Drugs Sales Volume, by Application (2017-2028)

    • Table North America Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Immuno-oncology Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Immuno-oncology Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Immuno-oncology Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Immuno-oncology Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Immuno-oncology Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Immuno-oncology Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Immuno-oncology Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Immuno-oncology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Immuno-oncology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Immuno-oncology Drugs Sales Value and Growth Rate (2017-2028)

    • Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Corporation Product Profiles, Application and Specification

    • Table Celgene Corporation Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Galena Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Galena Biopharma Product Profiles, Application and Specification

    • Table Galena Biopharma Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hoffmann-La Roche AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hoffmann-La Roche AG Product Profiles, Application and Specification

    • Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc Product Profiles, Application and Specification

    • Table Pfizer Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Prometheus Therapeutics & Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Prometheus Therapeutics & Diagnostics Product Profiles, Application and Specification

    • Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis International AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis International AG Product Profiles, Application and Specification

    • Table Novartis International AG Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table EMD Serono, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table EMD Serono, Inc Product Profiles, Application and Specification

    • Table EMD Serono, Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celldex Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celldex Therapeutics Product Profiles, Application and Specification

    • Table Celldex Therapeutics Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co Product Profiles, Application and Specification

    • Table Merck & Co Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi SA Product Profiles, Application and Specification

    • Table Sanofi SA Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Aduro BioTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Aduro BioTech Product Profiles, Application and Specification

    • Table Aduro BioTech Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca, Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca, Plc Product Profiles, Application and Specification

    • Table AstraZeneca, Plc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie, Inc Product Profiles, Application and Specification

    • Table AbbVie, Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ImmunoCellular Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ImmunoCellular Therapeutics Product Profiles, Application and Specification

    • Table ImmunoCellular Therapeutics Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Sciences Inc Product Profiles, Application and Specification

    • Table Gilead Sciences Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Incyte Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Incyte Product Profiles, Application and Specification

    • Table Incyte Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bavarian Nordic Product Profiles, Application and Specification

    • Table Bavarian Nordic Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen, Inc Product Profiles, Application and Specification

    • Table Amgen, Inc Immuno-oncology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.